調査レポート | • レポートコード：GIR-2104Z01002 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗肥満処方薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗肥満処方薬の種類別市場規模（小児、成人）、用途別市場規模（病院薬局、小売薬局、Eコマース）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗肥満処方薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：F Hoffmann La Roche Ltd、Orexigen Therapeutics、Novo Nordisk A/s、Arena Pharmaceuticals、Glaxosmithkline、Vivus、Boehringer Ingelheim、Alizyme ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：小児、成人 ・用途別分析2016年-2026年：病院薬局、小売薬局、Eコマース ・抗肥満処方薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗肥満処方薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗肥満処方薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗肥満処方薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗肥満処方薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti-Obesity Prescription Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anti-Obesity Prescription Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Anti-Obesity Prescription Drugs market size is expected to grow at a CAGR of 4.8% for the next five years.
Market segmentation
Anti-Obesity Prescription Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pediatric
Adult
Market segment by Application can be divided into
Hospitals Pharmacies
Retail Pharmacies
E-commerce
The key market players for global Anti-Obesity Prescription Drugs market are listed below:
F Hoffmann La Roche Ltd
Orexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Boehringer Ingelheim
Alizyme
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anti-Obesity Prescription Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Obesity Prescription Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Pediatric
1.2.3 Adult
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Obesity Prescription Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.4 Global Anti-Obesity Prescription Drugs Market Size & Forecast
1.4.1 Global Anti-Obesity Prescription Drugs Sales in Value (2016-2026))
1.4.2 Global Anti-Obesity Prescription Drugs Sales in Volume (2016-2026)
1.4.3 Global Anti-Obesity Prescription Drugs Price by Type (2016-2026) & (US$/Unit)
1.5 Global Anti-Obesity Prescription Drugs Production Capacity Analysis
1.5.1 Global Anti-Obesity Prescription Drugs Total Production Capacity (2016-2026)
1.5.2 Global Anti-Obesity Prescription Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Obesity Prescription Drugs Market Drivers
1.6.2 Anti-Obesity Prescription Drugs Market Restraints
1.6.3 Anti-Obesity Prescription Drugs Trends Analysis
2 Manufacturers Profiles
2.1 F Hoffmann La Roche Ltd
2.1.1 F Hoffmann La Roche Ltd Details
2.1.2 F Hoffmann La Roche Ltd Major Business
2.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product and Services
2.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Orexigen Therapeutics
2.2.1 Orexigen Therapeutics Details
2.2.2 Orexigen Therapeutics Major Business
2.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Product and Services
2.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novo Nordisk A/s
2.3.1 Novo Nordisk A/s Details
2.3.2 Novo Nordisk A/s Major Business
2.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Product and Services
2.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Arena Pharmaceuticals
2.4.1 Arena Pharmaceuticals Details
2.4.2 Arena Pharmaceuticals Major Business
2.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product and Services
2.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Glaxosmithkline
2.5.1 Glaxosmithkline Details
2.5.2 Glaxosmithkline Major Business
2.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Product and Services
2.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Vivus
2.6.1 Vivus Details
2.6.2 Vivus Major Business
2.6.3 Vivus Anti-Obesity Prescription Drugs Product and Services
2.6.4 Vivus Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business
2.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Product and Services
2.7.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Alizyme
2.8.1 Alizyme Details
2.8.2 Alizyme Major Business
2.8.3 Alizyme Anti-Obesity Prescription Drugs Product and Services
2.8.4 Alizyme Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anti-Obesity Prescription Drugs Sales by Manufacturer
3.1 Global Anti-Obesity Prescription Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anti-Obesity Prescription Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anti-Obesity Prescription Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Obesity Prescription Drugs Manufacturer Market Share
3.4.2 Top 6 Anti-Obesity Prescription Drugs Manufacturer Market Share
3.5 Global Anti-Obesity Prescription Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anti-Obesity Prescription Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-Obesity Prescription Drugs Market Size by Region
4.1.1 Global Anti-Obesity Prescription Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Anti-Obesity Prescription Drugs Revenue by Region (2016-2026)
4.2 North America Anti-Obesity Prescription Drugs Revenue (2016-2026)
4.3 Europe Anti-Obesity Prescription Drugs Revenue (2016-2026)
4.4 Asia-Pacific Anti-Obesity Prescription Drugs Revenue (2016-2026)
4.5 South America Anti-Obesity Prescription Drugs Revenue (2016-2026)
4.6 Middle East and Africa Anti-Obesity Prescription Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anti-Obesity Prescription Drugs Sales in Volume by Type (2016-2026)
5.2 Global Anti-Obesity Prescription Drugs Revenue by Type (2016-2026)
5.3 Global Anti-Obesity Prescription Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anti-Obesity Prescription Drugs Sales in Volume by Application (2016-2026)
6.2 Global Anti-Obesity Prescription Drugs Revenue by Application (2016-2026)
6.3 Global Anti-Obesity Prescription Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anti-Obesity Prescription Drugs Sales by Type (2016-2026)
7.2 North America Anti-Obesity Prescription Drugs Sales by Application (2016-2026)
7.3 North America Anti-Obesity Prescription Drugs Market Size by Country
7.3.1 North America Anti-Obesity Prescription Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Anti-Obesity Prescription Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-Obesity Prescription Drugs Sales by Type (2016-2026)
8.2 Europe Anti-Obesity Prescription Drugs Sales by Application (2016-2026)
8.3 Europe Anti-Obesity Prescription Drugs Market Size by Country
8.3.1 Europe Anti-Obesity Prescription Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Anti-Obesity Prescription Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Anti-Obesity Prescription Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Anti-Obesity Prescription Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anti-Obesity Prescription Drugs Sales by Type (2016-2026)
10.2 South America Anti-Obesity Prescription Drugs Sales by Application (2016-2026)
10.3 South America Anti-Obesity Prescription Drugs Market Size by Country
10.3.1 South America Anti-Obesity Prescription Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Anti-Obesity Prescription Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-Obesity Prescription Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Anti-Obesity Prescription Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Anti-Obesity Prescription Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-Obesity Prescription Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anti-Obesity Prescription Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anti-Obesity Prescription Drugs Typical Distributors
12.3 Anti-Obesity Prescription Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anti-Obesity Prescription Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anti-Obesity Prescription Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. F Hoffmann La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 4. F Hoffmann La Roche Ltd Major Business
Table 5. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product and Services
Table 6. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Orexigen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Orexigen Therapeutics Major Business
Table 9. Orexigen Therapeutics Anti-Obesity Prescription Drugs Product and Services
Table 10. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novo Nordisk A/s Basic Information, Manufacturing Base and Competitors
Table 12. Novo Nordisk A/s Major Business
Table 13. Novo Nordisk A/s Anti-Obesity Prescription Drugs Product and Services
Table 14. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Arena Pharmaceuticals Major Business
Table 17. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product and Services
Table 18. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table 20. Glaxosmithkline Major Business
Table 21. Glaxosmithkline Anti-Obesity Prescription Drugs Product and Services
Table 22. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Vivus Basic Information, Manufacturing Base and Competitors
Table 24. Vivus Major Business
Table 25. Vivus Anti-Obesity Prescription Drugs Product and Services
Table 26. Vivus Anti-Obesity Prescription Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 28. Boehringer Ingelheim Major Business
Table 29. Boehringer Ingelheim Anti-Obesity Prescription Drugs Product and Services
Table 30. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Alizyme Basic Information, Manufacturing Base and Competitors
Table 32. Alizyme Major Business
Table 33. Alizyme Anti-Obesity Prescription Drugs Product and Services
Table 34. Alizyme Anti-Obesity Prescription Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Anti-Obesity Prescription Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Anti-Obesity Prescription Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Anti-Obesity Prescription Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Anti-Obesity Prescription Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Anti-Obesity Prescription Drugs Production Site of Key Manufacturer
Table 40. Global Anti-Obesity Prescription Drugs Sales by Region (2016-2021e) & (K Units)
Table 41. Global Anti-Obesity Prescription Drugs Sales by Region (2021-2026) & (K Units)
Table 42. Global Anti-Obesity Prescription Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Anti-Obesity Prescription Drugs Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Anti-Obesity Prescription Drugs Sales by Type (2016-2021e) & (K Units)
Table 45. Global Anti-Obesity Prescription Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Global Anti-Obesity Prescription Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Anti-Obesity Prescription Drugs Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Anti-Obesity Prescription Drugs Price by Type (2016-2021e) & (US$/Unit)
Table 49. Global Anti-Obesity Prescription Drugs Price by Type (2021-2026) & (US$/Unit)
Table 50. Global Anti-Obesity Prescription Drugs Sales by Application (2016-2021e) & (K Units)
Table 51. Global Anti-Obesity Prescription Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Global Anti-Obesity Prescription Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Anti-Obesity Prescription Drugs Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Anti-Obesity Prescription Drugs Price by Application (2016-2021e) & (US$/Unit)
Table 55. Global Anti-Obesity Prescription Drugs Price by Application (2021-2026) & (US$/Unit)
Table 56. North America Anti-Obesity Prescription Drugs Sales by Country (2016-2021e) & (K Units)
Table 57. North America Anti-Obesity Prescription Drugs Sales by Country (2021-2026) & (K Units)
Table 58. North America Anti-Obesity Prescription Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Anti-Obesity Prescription Drugs Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Anti-Obesity Prescription Drugs Sales by Type (2016-2021e) & (K Units)
Table 61. North America Anti-Obesity Prescription Drugs Sales by Type (2021-2026) & (K Units)
Table 62. North America Anti-Obesity Prescription Drugs Sales by Application (2016-2021e) & (K Units)
Table 63. North America Anti-Obesity Prescription Drugs Sales by Application (2021-2026) & (K Units)
Table 64. Europe Anti-Obesity Prescription Drugs Sales by Country (2016-2021e) & (K Units)
Table 65. Europe Anti-Obesity Prescription Drugs Sales by Country (2021-2026) & (K Units)
Table 66. Europe Anti-Obesity Prescription Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Anti-Obesity Prescription Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Anti-Obesity Prescription Drugs Sales by Type (2016-2021e) & (K Units)
Table 69. Europe Anti-Obesity Prescription Drugs Sales by Type (2021-2026) & (K Units)
Table 70. Europe Anti-Obesity Prescription Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. Europe Anti-Obesity Prescription Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Asia-Pacific Anti-Obesity Prescription Drugs Sales by Region (2016-2021e) & (K Units)
Table 73. Asia-Pacific Anti-Obesity Prescription Drugs Sales by Region (2021-2026) & (K Units)
Table 74. Asia-Pacific Anti-Obesity Prescription Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Anti-Obesity Prescription Drugs Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Anti-Obesity Prescription Drugs Sales by Type (2016-2021e) & (K Units)
Table 77. Asia-Pacific Anti-Obesity Prescription Drugs Sales by Type (2021-2026) & (K Units)
Table 78. Asia-Pacific Anti-Obesity Prescription Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. Asia-Pacific Anti-Obesity Prescription Drugs Sales by Application (2021-2026) & (K Units)
Table 80. South America Anti-Obesity Prescription Drugs Sales by Country (2016-2021e) & (K Units)
Table 81. South America Anti-Obesity Prescription Drugs Sales by Country (2021-2026) & (K Units)
Table 82. South America Anti-Obesity Prescription Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Anti-Obesity Prescription Drugs Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Anti-Obesity Prescription Drugs Sales by Type (2016-2021e) & (K Units)
Table 85. South America Anti-Obesity Prescription Drugs Sales by Type (2021-2026) & (K Units)
Table 86. South America Anti-Obesity Prescription Drugs Sales by Application (2016-2021e) & (K Units)
Table 87. South America Anti-Obesity Prescription Drugs Sales by Application (2021-2026) & (K Units)
Table 88. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Country (2016-2021e) & (K Units)
Table 89. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Country (2021-2026) & (K Units)
Table 90. Middle East & Africa Anti-Obesity Prescription Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Anti-Obesity Prescription Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Type (2016-2021e) & (K Units)
Table 93. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Type (2021-2026) & (K Units)
Table 94. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Application (2016-2021e) & (K Units)
Table 95. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Application (2021-2026) & (K Units)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Anti-Obesity Prescription Drugs Typical Distributors
Table 99. Anti-Obesity Prescription Drugs Typical Customers
List of Figures
Figure 1. Anti-Obesity Prescription Drugs Picture
Figure 2. Global Anti-Obesity Prescription Drugs Sales Market Share by Type in 2020
Figure 3. Pediatric
Figure 4. Adult
Figure 5. Global Anti-Obesity Prescription Drugs Sales Market Share by Application in 2020
Figure 6. Hospitals Pharmacies
Figure 7. Retail Pharmacies
Figure 8. E-commerce
Figure 9. Global Anti-Obesity Prescription Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Anti-Obesity Prescription Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Anti-Obesity Prescription Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Anti-Obesity Prescription Drugs Sales (2016-2026) & (K Units)
Figure 31. Global Anti-Obesity Prescription Drugs Production Capacity (2016-2026) & (K Units)
Figure 32. Global Anti-Obesity Prescription Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Anti-Obesity Prescription Drugs Market Drivers
Figure 34. Anti-Obesity Prescription Drugs Market Restraints
Figure 35. Anti-Obesity Prescription Drugs Market Trends
Figure 36. Global Anti-Obesity Prescription Drugs Sales Market Share by Manufacturer in 2020
Figure 37. Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2020
Figure 38. Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Anti-Obesity Prescription Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Anti-Obesity Prescription Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Anti-Obesity Prescription Drugs Sales Market Share by Region (2016-2026)
Figure 42. Global Anti-Obesity Prescription Drugs Revenue Market Share by Region (2016-2026)
Figure 43. North America Anti-Obesity Prescription Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Europe Anti-Obesity Prescription Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Anti-Obesity Prescription Drugs Revenue (2016-2026) & (USD Million)
Figure 46. South America Anti-Obesity Prescription Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Anti-Obesity Prescription Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Global Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2026)
Figure 49. Global Anti-Obesity Prescription Drugs Revenue Market Share by Type (2016-2026)
Figure 50. Global Anti-Obesity Prescription Drugs Price by Type (2016-2026) & (US$/Unit)
Figure 51. Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2026)
Figure 52. Global Anti-Obesity Prescription Drugs Revenue Market Share by Application (2016-2026)
Figure 53. Global Anti-Obesity Prescription Drugs Price by Application (2016-2026) & (US$/Unit)
Figure 54. North America Anti-Obesity Prescription Drugs Sales Market Share by Country (2016-2026)
Figure 55. North America Anti-Obesity Prescription Drugs Revenue Market Share by Country (2016-2026)
Figure 56. North America Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2026)
Figure 57. North America Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2026)
Figure 58. Europe Anti-Obesity Prescription Drugs Sales Market Share by Country (2016-2026)
Figure 59. Europe Anti-Obesity Prescription Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Europe Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2026)
Figure 61. Europe Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Anti-Obesity Prescription Drugs Sales Market Share by Country (2016-2026)
Figure 67. South America Anti-Obesity Prescription Drugs Revenue Market Share by Country (2016-2026)
Figure 68. South America Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Anti-Obesity Prescription Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の抗肥満薬市場 2021：企業別、地域別、種類・用途別 The Anti-Obesity Drugs (Anti-obesity Medication) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 世界の抗肥満薬市場規模・現状・予測（2021年-2027年） Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. Market Analysis and Insights: Global Anti-obesity Medicine Market The global Anti-obesity Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a …
- 抗肥満薬の世界市場2020年：分析と予測（～2025年） This report describes the global market size of Anti-obesity Drug from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 2015 to 202…
- 世界の処方皮膚科治療市場 2021：企業別、地域別、種類・用途別 The Prescription Dermatology Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界の抗自殺薬市場 2021：企業別、地域別、種類・用途別 The Anti-Suicide Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…